Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
Public ClinicalTrials.gov record NCT00109161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This research study is being conducted in the U.S. and Europe to evaluate the safety and efficacy of daclizumab for the treatment of multiple sclerosis (MS).
Study identification
- NCT ID
- NCT00109161
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 270 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2005
- Primary completion
- Not listed
- Completion
- Sep 30, 2006
- Last update posted
- Aug 4, 2008
2005 – 2006
United States locations
- U.S. sites
- 30
- U.S. states
- 19
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| Mayo Clinic | Scottsdale | Arizona | 85013 | — |
| Sutter East Bay Medical Foundation | Berkeley | California | 94705 | — |
| Neurology Associates, P.A. | Maitland | Florida | 32751 | — |
| The Multiple Sclerosis Center of Atlanta | Atlanta | Georgia | 30327 | — |
| Consultants in Neurology | Northbrook | Illinois | 60062 | — |
| KUMC Neurology | Kansas City | Kansas | 66160 | — |
| Louisiana State University Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| Maryland Center for MS | Baltimore | Maryland | 21201 | — |
| Wayne State University MS Center | Detroit | Michigan | 48201 | — |
| Michigan State University | East Lansing | Michigan | 48824 | — |
| Michigan Medical P.C. Neurology | Grand Rapids | Michigan | 49525 | — |
| St. Louis University Hospital | St Louis | Missouri | 63110 | — |
| MS Center at Dartmouth | Lebanon | New Hampshire | 03756 | — |
| Gimble MS Center | Teaneck | New Jersey | 07666 | — |
| Upstate Clinical Research | Albany | New York | 12205 | — |
| Albany Medical Center | Albany | New York | 12208 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| Hospital for Joint Diseases, MS Care Center | New York | New York | 10003 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| MS Center/CMC Meyers Park | Charlotte | North Carolina | 28207 | — |
| Raleigh Neurology Associates | Raleigh | North Carolina | 27607 | — |
| University of Cincinnati | Cincinnati | Ohio | 45219 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| The MS Center at Texas Neurology | Dallas | Texas | 75214 | — |
| Central Texas Neurology | Round Rock | Texas | 78681 | — |
| University of Utah CAMT | Salt Lake City | Utah | 84108 | — |
| MS Hub Medical Group | Seattle | Washington | 98101 | — |
| Rockwood Clinic, PS | Spokane | Washington | 99202 | — |
| Wenatchee Valley Medical Center | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
Recently updated Multiple Sclerosis trials
Other public records listing Multiple Sclerosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07779460: A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice Recruiting
- NCT07768761: Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis Recruiting
- NCT07759115: Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study Not yet recruiting
- NCT05057676: Autoimmune Intervention Mastery Course Study Active, not recruiting
- NCT06233370: Acute Effects of Walking Exercise on Brain Functioning in Multiple Sclerosis Active, not recruiting
- NCT07115017: This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis. Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00109161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2008 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00109161 live on ClinicalTrials.gov.